Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,614 | 96,938 | 100,808 | 128,763 | 71,891 |
| Receivables | 118,145 | 114,916 | 118,129 | 106,005 | 103,228 |
| Inventories | 206,919 | 171,806 | 171,261 | 146,928 | 140,240 |
| Income taxes - deferred | 48,616 | 39,100 | 36,155 | 35,284 | 29,972 |
| TOTAL | $521,152 | $453,051 | $452,257 | $444,849 | $365,363 |
| Non-Current Assets | |||||
| PPE Net | 200,310 | 177,898 | 131,383 | 99,456 | 83,526 |
| Intangibles | 446,927 | 506,334 | 530,102 | 456,832 | 473,058 |
| Other Non-Current Assets | 23,750 | 26,316 | 30,367 | 17,996 | 18,155 |
| TOTAL | $670,987 | $710,548 | $691,852 | $574,284 | $574,739 |
| Total Assets | $1,192,139 | $1,163,599 | $1,144,109 | $1,019,133 | $940,102 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 76,760 |
| Accounts payable and accrued liabilities | 50,752 | 36,742 | 27,656 | 27,783 | 24,598 |
| Accrued Expenses | 64,433 | 66,682 | 69,669 | 61,192 | 51,295 |
| TOTAL | $119,382 | $106,929 | $101,868 | $201,857 | $156,730 |
| Non-Current Liabilities | |||||
| Long Term Debt | 186,875 | 321,875 | 179,688 | 139,688 | 160,000 |
| Deferred Revenues | 4,197 | 3,505 | 4,543 | 4,444 | 4,077 |
| Other Non-Current Liabilities | 217,709 | 211,627 | 364,189 | 166,980 | 169,168 |
| TOTAL | $406,667 | $538,895 | $549,603 | $317,313 | $338,487 |
| Total Liabilities | $526,049 | $645,824 | $651,471 | $519,170 | $495,217 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,826 | 55,978 | 53,760 | 57,208 | 57,358 |
| Common Shares | 410 | 369 | 357 | 355 | 350 |
| Retained earnings | 280,956 | 302,023 | 260,819 | 232,830 | 167,161 |
| Other shareholders' equity | 806 | -4,918 | -9,214 | -1,453 | 8,525 |
| TOTAL | $666,090 | $517,775 | $492,638 | $499,963 | $444,885 |
| Total Liabilities And Equity | $1,192,139 | $1,163,599 | $1,144,109 | $1,019,133 | $940,102 |